Chemomab Announces Completion of Patient Enrollment in CM-10

Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary Sclerosing Cholangitis Trial and Moves Up Expected Topline Readout to Midyear 2024

Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary Sclerosing Cholangitis Trial and Moves Up Expected Topline Readout to Midyear 2024

lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Israel , Matt Frankel , Wadi Mor , Barbara Lindheim , Strategic Communications , Us Food Drug Administration , European Union , Nasdaq , Chemomab Therapeutics Ltd , Announces Completion , Patient Enrollment , Sclerosing Cholangitis Trial , Moves Up Expected Topline Readout , Expected Topline Data Readout Accelerated , Early Completion , Sclerosing Cholangitis , Dual Anti Fibrotic , Which Often Results , Liver Transplant , Lacks Any , Chemomab Therapeutics , Chief Executive Officer , Chief Scientific Officer , Orphan Drug , Fast Track , Drug Administration , Chief Medical Officer Matt Frankel , Private Securities Litigation Reform , Vice President , Public Relations ,